Company News
MagicTouch SCB Matches Stent at 1 Year
The TRANSFORM II trial enrolled 1,842 patients across 53 centres in 11 countries to compare MagicTouch sirolimus‑coated balloon with everolimus‑eluting stents.
At 12 months, target lesion failure was
